Institut Curie ( Site 0400)

Paris 75005

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Non-Small Cell Lung Cancer

Studies at this site

• Efficacy and Safety of Pembrolizumab (MK-3475) With Lenvatinib (E7080/MK-7902) vs. Docetaxel in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) and Progressive Disease (PD) After Platinum Doublet Chemotherapy and Immunotherapy (MK-7902-008/E7080-G000-316/LEAP-008) — Completed